201 related articles for article (PubMed ID: 34484309)
21. Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin
Zhou Q; Wang Z; Zeng H; Zhang H; Liu Z; Huang Q; Wang J; Chang Y; Bai Q; Liu L; Zhu Y; Xu L; Dai B; Guo J; Xia Y; Wang Y; Xu J
Oncoimmunology; 2020 Apr; 9(1):1747333. PubMed ID: 33457092
[TBL] [Abstract][Full Text] [Related]
22. Skin Wound Repair Is Not Altered in the Absence of Endogenous AnxA1 or AnxA5, but Pharmacological Concentrations of AnxA4 and AnxA5 Inhibit Wound Hemostasis.
Kreft S; Klatt AR; Straßburger J; Pöschl E; Flower RJ; Eming S; Reutelingsperger C; Brisson A; Brachvogel B
Cells Tissues Organs; 2016; 201(4):287-98. PubMed ID: 27178140
[TBL] [Abstract][Full Text] [Related]
23. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.
Efstathiou JA; Mouw KW; Gibb EA; Liu Y; Wu CL; Drumm MR; da Costa JB; du Plessis M; Wang NQ; Davicioni E; Feng FY; Seiler R; Black PC; Shipley WU; Miyamoto DT
Eur Urol; 2019 Jul; 76(1):59-68. PubMed ID: 30712971
[TBL] [Abstract][Full Text] [Related]
24. Mapping the tumor microenvironment in bladder cancer and exploring the prognostic genes by single-cell RNA sequencing.
Chen Z; Chen D; Song Z; Lv Y; Qi D
Front Oncol; 2022; 12():1105026. PubMed ID: 36741702
[TBL] [Abstract][Full Text] [Related]
25. History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy.
Kayama E; Kikuchi E; Fukumoto K; Shirotake S; Miyazaki Y; Hakozaki K; Kaneko G; Yoshimine S; Tanaka N; Takahiro M; Kanai K; Oyama M; Nakajima Y; Hara S; Monma T; Oya M
Clin Genitourin Cancer; 2018 Oct; 16(5):e969-e976. PubMed ID: 29778322
[TBL] [Abstract][Full Text] [Related]
26. Integrative Transcriptomic, Lipidomic, and Metabolomic Analysis Reveals Potential Biomarkers of Basal and Luminal Muscle Invasive Bladder Cancer Subtypes.
Feng C; Pan L; Tang S; He L; Wang X; Tao Y; Xie Y; Lai Z; Tang Z; Wang Q; Li T
Front Genet; 2021; 12():695662. PubMed ID: 34484294
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
[TBL] [Abstract][Full Text] [Related]
28. Utility of SAM68 in the progression and prognosis for bladder cancer.
Zhang Z; Yu C; Li Y; Jiang L; Zhou F
BMC Cancer; 2015 May; 15():364. PubMed ID: 25944080
[TBL] [Abstract][Full Text] [Related]
29. FLIM-FRET-based analysis of S100A11/annexin interactions in living cells.
Melle C; Hoffmann B; Wiesenburg A; Biskup C
FEBS Open Bio; 2024 Apr; 14(4):626-642. PubMed ID: 38408765
[TBL] [Abstract][Full Text] [Related]
30.
Pignot G; Le Goux C; Vacher S; Schnitzler A; Radvanyi F; Allory Y; Lallemand F; Delongchamps NB; Zerbib M; Terris B; Damotte D; Bieche I
Oncol Lett; 2019 Oct; 18(4):3471-3480. PubMed ID: 31516565
[TBL] [Abstract][Full Text] [Related]
31. Analysis of bladder cancer subtypes in neurogenic bladder tumors.
Manach Q; Cussenot O; Rouprêt M; Gamé X; Chartier-Kastler E; Reus C; Camparo P; Compérat E; Phé V
Can J Urol; 2018 Feb; 25(1):9161-9167. PubMed ID: 29524970
[TBL] [Abstract][Full Text] [Related]
32. Triple-marker immunohistochemical assessment of muscle-invasive bladder cancer: Is there prognostic significance?
Labban M; Najdi J; Mukherji D; Abou-Kheir W; Tabbarah A; El-Hajj A
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1313. PubMed ID: 33538412
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Implications of Immunohistochemical Biomarkers in Non-muscle-invasive Blad Cancer and Muscle-invasive Bladder Cancer.
Boegemann M; Krabbe LM
Mini Rev Med Chem; 2020; 20(12):1133-1152. PubMed ID: 27173513
[TBL] [Abstract][Full Text] [Related]
34. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
[TBL] [Abstract][Full Text] [Related]
35. The evolution of bladder cancer genomics: What have we learned and how can we use it?
Audenet F; Attalla K; Sfakianos JP
Urol Oncol; 2018 Jul; 36(7):313-320. PubMed ID: 29573965
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of family history among patients with urinary bladder cancer.
Egbers L; Grotenhuis AJ; Aben KK; Alfred Witjes J; Kiemeney LA; Vermeulen SH
Int J Cancer; 2015 Mar; 136(5):1117-24. PubMed ID: 24978702
[TBL] [Abstract][Full Text] [Related]
37. Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer.
Shen C; Xu T; Sun Y; Wang L; Liang Z; Niu H; Jiao W; Wang Y
Dis Markers; 2020; 2020():8866730. PubMed ID: 33456631
[TBL] [Abstract][Full Text] [Related]
38. Expression and Prognostic Significance of the MMP Family Molecules in Bladder Cancer.
Shen C; Da L; Wu Z; Wang Y; Gao S; Tian D; Hu H
Comb Chem High Throughput Screen; 2021; 24(8):1183-1196. PubMed ID: 32940175
[TBL] [Abstract][Full Text] [Related]
39. Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing.
Wang F; Dong X; Yang F; Xing N
Front Genet; 2022; 13():831146. PubMed ID: 35419031
[No Abstract] [Full Text] [Related]
40. Dynamic expression changes between non-muscle-invasive bladder cancer and muscle-invasive bladder cancer.
Zhao YG; Shi BY; Qian YY; Bai HW; Xiao L; He XY
Tumori; 2014; 100(6):e273-81. PubMed ID: 25688510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
